$1M Healthcare Innovation Award to Fight Child Mortality GlaxoSmithKline & Save the Children initiated a new challenge on the innocentive website: A million US dollar Healthcare Innovation Award to Fight Child Mortality. Innocentive is one of the leading open innovation platforms who claims to have a very high success rate in completing project targets with the support of external scientists and problem solvers. The award fund has been made available by the pharma giant GlaxoSmithKline (GSK) for organisations practicing innovative approaches to reduce mortality rates in children under-5 years. The initiators GSK and Save the Children will jointly evaluate nominated organisations and select organisations for a monetary award.  Award winners selected by GSK and Save the Children will be publically announced and their innovative practices promoted within 3 months of the end of the nomination period. The challenge says “GlaxoSmithKline and Save the Children have launched a fund totalling $1,000,000 to reward organisations practicing innovative approaches for reducing under-5 child mortality. The organisation judged to combat child mortality in the most innovative and effective way will be eligible for an award of up to $250,000. Eligible innovative organisations can come from the non-profit, private or public sector, if both the organisation and the innovation are from the developing world. Nominations can be submitted by the organisation themselves, or by a third-party organisation or individual, through a brief questionnaire found within the detailed guidelines.”